Page 41 - 80_01

Elvira
López-­-Oliva
Muñoz,
Emilia
Muñoz
Martínez

23. Donnelly,
K.L.,
Smith,
C.I.,
Schwarzenberg,
S.J.
y
col.
2005.
Sources
of
fatty
acids
stored
in

liver
and
secreted
via
lipoproteins
in
patients
with
nonalcoholic
fatty
liver
disease.
J
Clin

Invest
115,
1343-­-1351.

24. Ginsberg,
H.N.,
Zhang,
Y.L.,
Hernandez-­-Ono,
A.,
2005.
Regulation
of
plasma
triglycerides
in

insulin
resistance
and
diabetes.
Arch
Med
Res
36,
232-­-240.

25. Greco,
D.,
Kotronen,
A.,
Westerbacka,
J.
y
col.
2008.
Gene
expression
in
human
NAFLD.
Am

J
Physiol
Gastrointest
Liver
Physiol
294,
G1281-­-1287.

26.
Hubbard,
B.,
Doege,
H.,
Punreddy,
S.
y
col.
2006.
Mice
deleted
for
fatty
acid

transport
protein
5
have
defective
bile
acid
conjugation
and
are
protected
from
obesity.

Gastroenterology
130,
1259-­-1269.

27.
Fabbrini,
E.,
Sullivan,
S.,
Klein,
S.,
2010.
Obesity
and
nonalcoholic
fatty
liver

disease:
biochemical,
metabolic,
and
clinical
implications.
Hepatology
51,
679-­-689.

28.
Foufelle,
F.,
Ferré,
P.,
2002.
New
perspectives
in
the
regulation
of
hepatic

glycolytic
and
lipogenic
genes
by
insulin
and
glucose:
a
role
for
the
transcription
factor

sterol
regulatory
element
binding
protein-­-1c.

29.
Munday,
M.R.,
2002.
Regulation
of
mammalian
acetyl-­-CoA
carboxylase.
Biochem

Soc
Trans
30,
1059-­-1064.

30.
Smith,
S.,
Witkowski,
A.,
Joshi,
A.K.,
2003.
Structural
and
functional
organization
of

the
animal
fatty
acid
synthase.
Prog
Lipid
Res
42,
289-­-317.

31.
Ntambi,
J.M.,
Miyazaki,
M.,
2004.
Regulation
of
stearoyl-­-CoA
desaturases
and
role

in
metabolism.
Prog
Lipid
Res
43,
91-­-104.

32.
Yen,
C.L.,
Stone,
S.J.,
Koliwad,
S.
y
col.
2008.
Thematic
review
series:
glycerolipids.

DGAT
enzymes
and
triacylglycerol
biosynthesis.
J
Lipid
Res
49,
2283-­-2301.

33.
Chen,
G.,
Liang,
G.,
Ou,
J.
y
col.
2004.
Central
role
for
liver
X
receptor
in
insulin-­-

mediated
activation
of
Srebp-­-1c
transcription
and
stimulation
of
fatty
acid
synthesis
in

liver.
Proc
Natl
Acad
Sci
U
S
A
101,
11245-­-11250.

34.
Shimano,
H.,
2001.
Sterol
regulatory
element-­-binding
proteins
(SREBPs):

transcriptional
regulators
of
lipid
synthetic
genes.
Prog
Lipid
Res
40,
439-­-452.

35.
Dentin,
R.,
Girard,
J.,
Postic,
C.,
2005.
Carbohydrate
responsive
element
binding

protein
(ChREBP)
and
sterol
regulatory
element
binding
protein-­-1c
(SREBP-­-1c):
two
key

regulators
of
glucose
metabolism
and
lipid
synthesis
in
liver.
Biochimie
87,
81-­-86.

36. Tessari,
P.,
Coracina,
A.,
Cosma,
A.,
Tiengo,
A.,
2009.
Hepatic
lipid
metabolism
and
non-­-

alcoholic
fatty
liver
disease.
Nutr
Metab
Cardiovasc
Dis
19,
291-­-302.

37. Kotronen,
A.,
Seppälä-­-Lindroos,
A.,
Vehkavaara,
S.
y
col.
2009.
Liver
fat
and
lipid
oxidation

in
humans.
Liver
Int
29,
1439-­-1446.

38. Lavoie,
J.M.,
Gauthier,
M.S.,
2006.
Regulation
of
fat
metabolism
in
the
liver:
link
to
non-­-

alcoholic
hepatic
steatosis
and
impact
of
physical
exercise.
Cell
Mol
Life
Sci
63,
1393-­-1409.

39. Reddy,
J.K.,
Rao,
M.S.,
2006.
Lipid
metabolism
and
liver
inflammation.
II.
Fatty
liver
disease

and
fatty
acid
oxidation.
Am
J
Physiol
Gastrointest
Liver
Physiol
290,
G852-­-858.

40. Leclercq,
I.A.,
Farrell,
G.C.,
Field,
J.
y
col.
2000.
CYP2E1
and
CYP4A
as
microsomal
catalysts

of
lipid
peroxides
in
murine
nonalcoholic
steatohepatitis.
J
Clin
Invest
105,
1067-­-1075.

41. Louet,
J.F.,
Chatelain,
F.,
Decaux,
J.F.
y
col.
2001.
Long-­-chain
fatty
acids
regulate
liver

carnitine
palmitoyltransferase
I
gene
(L-­-CPT
I)
expression
through
a
peroxisome-­-

proliferator-­-activated
receptor
alpha
(PPARalpha)-­-independent
pathway.
Biochem
J
354,

189-­-197.

42. Reddy,
J.K.,
Hashimoto,
T.,
2001.
Peroxisomal
beta-­-oxidation
and
peroxisome
proliferator-­-

activated
receptor
alpha:
an
adaptive
metabolic
system.
Annu
Rev
Nutr
21,
193-­-230.

43. Akiyama,
T.E.,
Nicol,
C.J.,
Fievet,
C.
y
col.
2001.
Peroxisome
proliferator-­-activated
receptor-­-
alpha
regulates
lipid
homeostasis,
but
is
not
associated
with
obesity:
studies
with
congenic

mouse
lines.
J
Biol
Chem
276,
39088-­-39093.

44. Stienstra,
R.,
Mandard,
S.,
Patsouris,
D.
y
col.
2007.
Peroxisome
proliferator-­-activated

receptor
alpha
protects
against
obesity-­-induced
hepatic
inflammation.
Endocrinology
148,

2753-­-2763.

45.
Harano,
Y.,
Yasui,
K.,
Toyama,
T.
y
col.
2006.
Fenofibrate,
a
peroxisome

proliferator-­-activated
receptor
alpha
agonist,
reduces
hepatic
steatosis
and
lipid

peroxidation
in
fatty
liver
Shionogi
mice
with
hereditary
fatty
liver.
Liver
Int
26,
613-­-620.

46.
Adiels,
M.,
Taskinen,
M.R.,
Packard,
C.
y
col.
2006.
Overproduction
of
large
VLDL

particles
is
driven
by
increased
liver
fat
content
in
man.
Diabetologia
49,
755-­-765.

40